Johnson & Johnson (NYSE:JNJ) will release earnings for its first quarter before the opening bell on Tuesday, April 14.
Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings of $2.67 per share, down from $2.77 per share in the year-ago period. The consensus estimate for Johnson & Johnson’s quarterly revenue is $23.6 billion (it reported $21.89 billion last year), according to Benzinga Pro.
On March 12, Johnson & Johnson announced the FDA approval of TECNIS PureSee Intraocular Lens intended for use in cataract surgery.
Johnson & Johnson shares gained 1.2% to close at $241.30 on Wednesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
This post was originally published here
